Core Viewpoint - Significant changes in the shareholder structure of Junlebao are observed, with new investments from Moutai Group and other notable investment firms, indicating strong confidence from the founder and core team in the company's future development [1] Group 1: Shareholder Changes - By December 2025, Junlebao's shareholder list will include new investors such as Moutai Jinshi (Guizhou) Biotechnology Industry Fund and Qiongcheng Fuman Venture Capital, managed by Jinding Capital [1] - Existing shareholders, including Housheng Capital's Quanzhou Haisi Houjiu Equity Investment Partnership, have increased their stakes in the company [1] Group 2: Founder and Core Team's Stake Increase - The founder Wei Lihua and his core team have increased their holdings from approximately 15.00% to 20.61%, representing a total increase of about 5.61% [1] - The estimated amount for this increase in holdings exceeds 1.1 billion yuan, as all dividends received over the past three years were reinvested into this stake increase [1] Group 3: Market Implications - The substantial increase in holdings by the founder and core team before the company's IPO is seen as a strong signal of confidence in the company's fundamentals and future prospects, potentially reassuring future investors in the Hong Kong stock market [1]
君乐宝创始人及核心团队在上市前大额增持公司股份 凸显强烈信心
Zheng Quan Ri Bao Wang·2026-02-05 12:42